MACROGENICS Trademark

Trademark Overview

On Friday, August 27, 2010, a trademark application was filed for MACROGENICS with the United States Patent and Trademark Office. The USPTO has given the MACROGENICS trademark a serial number of 85117467. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, October 25, 2022. This trademark is owned by MacroGenics, Inc.. The MACROGENICS trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Production and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [ allergies, ] cancer, and infectious diseases

Discovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [ allergies, ] cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology
macrogenics

General Information

Serial Number85117467
Word MarkMACROGENICS
Filing DateFriday, August 27, 2010
Status800 - REGISTERED AND RENEWED
Status DateTuesday, October 25, 2022
Registration Number4139795
Registration DateTuesday, May 8, 2012
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2011

Trademark Statements

Goods and ServicesProduction and product commercialization for third parties of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [ allergies, ] cancer, and infectious diseases
Goods and ServicesDiscovery, research, and development of pharmaceuticals and substances for the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, [ allergies, ] cancer, and infectious diseases; Discovery, research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and biotechnology

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, May 26, 2011
Primary Code035
First Use Anywhere DateMonday, August 14, 2000
First Use In Commerce DateMonday, August 14, 2000
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 1, 2010
Primary Code042
First Use Anywhere DateMonday, August 14, 2000
First Use In Commerce DateMonday, August 14, 2000

Trademark Owner History

Party NameMacroGenics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameMacroGenics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameMacroGenics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Friday, December 10, 2010ASSIGNED TO EXAMINER
Thursday, May 26, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 31, 2010NEW APPLICATION ENTERED
Wednesday, September 1, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 14, 2010NON-FINAL ACTION WRITTEN
Tuesday, December 14, 2010NON-FINAL ACTION E-MAILED
Tuesday, December 14, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 24, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 26, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 26, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 5, 2012USE AMENDMENT FILED
Thursday, March 29, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2011ASSIGNED TO LIE
Tuesday, June 14, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 19, 2011PUBLISHED FOR OPPOSITION
Tuesday, July 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 5, 2012TEAS STATEMENT OF USE RECEIVED
Friday, March 30, 2012STATEMENT OF USE PROCESSING COMPLETE
Saturday, August 5, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, August 5, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, April 3, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 3, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, April 4, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 8, 2012REGISTERED-PRINCIPAL REGISTER
Monday, May 8, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 22, 2017TEAS SECTION 8 & 15 RECEIVED
Saturday, August 5, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, March 1, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 1, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 1, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 1, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 1, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, May 8, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, April 26, 2022TEAS SECTION 8 & 9 RECEIVED
Tuesday, October 25, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, October 25, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, October 25, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, October 25, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

macrogenics research disorders diseases development pharmaceuticals biotechnology fields allergies infectious pharmaceutical